Absence of Genotypic Drug Resistance and Presence of Several Naturally Occurring Polymorphisms of Human Immunodeficiency Virus-1 CRF06_cpx in Treatment-Naive Patients in Estonia

被引:18
作者
Avi, Radko [1 ]
Huik, Kristi [1 ]
Sadam, Maarja [1 ]
Karki, Tonis [1 ]
Krispin, Tonu [1 ]
Ainsalu, Kuelliki [2 ]
Paap, Piret [3 ]
Schmidt, Jelena [4 ]
Nikitina, Natalia [4 ]
Lutsar, Irja [1 ]
机构
[1] Univ Tartu, Fac Med, Dept Microbiol, EE-50111 Tartu, Estonia
[2] Tartu Univ Hosp, Dept Infect Dis, Tartu, Estonia
[3] Hosp Tartu Prison, Tartu, Estonia
[4] Ida Viru Cent Hosp, Kohtla Jarve, Estonia
关键词
natural polymorphism; drug resistance mutation; protease; revertase; FORMER SOVIET-UNION; HIV TYPE-1; SUBTYPE-B; MUTATIONS; PROTEASE; RECOMBINANT; STRAINS; EPIDEMIOLOGY; DIVERSITY; THERAPY;
D O I
10.1002/jmv.21482
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
All non-B HIV-1 subtypes and circulating recombinant forms (CRFs) are characterized by several polymorphisms in protease (PR) region. In addition, in recent years the increasing use of antiretroviral treatment (ART) has rapidly raised the spread of transmitted drug resistance. We aimed to determine the presence of naturally Occurring polymorphisms and transmitted drug resistance mutations (DRMs) in ART naive HIV-1-positive subjects in Estonia. A total of 115 drug-naive HIV-1-infected subjects (mean age 27 years; 70% male; 65% infected via intravenous drug use and 34% by heterosexual contact) were enrolled. Viral genomic RNA from plasma was directly sequenced in PR, revertase (RT), and envelope (env) regions. Phylogenetic analysis of RT and env regions revealed that 89% and 3% of sequenced viruses belonged to CRF06_cpx and subtype All, respectively, and 6% were described as unique recombinants (signed A1-06) between CRF06_cpx and subtype All viruses. No primary DRMs were found in PR or RT regions indicating the absence of transmitted drug resistance. The most common polymorphisms in the PR region were K14R, M36I, H69K, and L89M seen in 96%, 100%, 99%, and 100%, respectively. The clinical relevance of these polymorphisms in terms of success of ART has to be monitored in future clinical studies. J. Med. Virol. 81:953-958, 2009. (c) 2009 Wiley-Liss, Inc.
引用
收藏
页码:953 / 958
页数:6
相关论文
共 28 条
[11]   An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination [J].
Liitsola, K ;
Holm, K ;
Bobkov, A ;
Pokrovsky, V ;
Smolskaya, T ;
Leinikki, P ;
Osmanov, S ;
Salminen, M .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (11) :1047-1053
[12]   Genetic characterization of HIV-1 strains in the Baltic countries and Russia [J].
Liitsola, K ;
Laukkanen, T ;
Denisova, A ;
Grishkevichius, A ;
Smolskaja, T ;
Ustina, V ;
Vlasov, N ;
Leinikki, P ;
Salminen, MO .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (06) :537-541
[13]   HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy [J].
Monno, L ;
Brindicci, G ;
Lo Caputo, S ;
Punzi, G ;
Scarabaggio, T ;
Riva, C ;
Di Bari, C ;
Pierotti, P ;
Saracino, A ;
Lagioia, A ;
Mazzotta, F ;
Balotta, C ;
Angarano, G .
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (04) :483-490
[14]  
Montavon C, 2002, J ACQ IMMUN DEF SYND, V29, P522, DOI 10.1097/00126334-200204150-00014
[15]   Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major Drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B [J].
Ndembi, Nicaise ;
Abraha, Awet ;
Pilch, Heather ;
Ichimura, Hiroshi ;
Mbanya, Dora ;
Kaptue, Lazare ;
Salata, Robert ;
Arts, Eric J. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) :177-184
[16]   Computational characterization of structural role of the non-active site mutation M36I of human immunodeficiency virus type 1 protease [J].
Ode, Hirotaka ;
Matsuyama, Shou ;
Hata, Masayuki ;
Neya, Saburo ;
Kakizawa, Junko ;
Sugiura, Wataru ;
Hoshino, Tyuji .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 370 (03) :598-607
[17]   Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations [J].
Ode, Hirotaka ;
Matsuyama, Shou ;
Hata, Masayuki ;
Hoshino, Tyuji ;
Kakizawa, Junko ;
Sugiura, Wataru .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) :1768-1777
[18]   Computational simulations of HIV-1 proteases-multi-drug resistance due to nonactive site mutation L90M [J].
Ode, Hirotaka ;
Neya, Saburo ;
Hata, Masayuki ;
Sugiura, Wataru ;
Hoshino, Tyuji .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (24) :7887-7895
[19]   Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy [J].
Perno, CF ;
Cozzi-Lepri, A ;
Balotta, C ;
Forbici, F ;
Violin, M ;
Bertoli, A ;
Facchi, G ;
Pezzotti, P ;
Cadeo, G ;
Tositti, G ;
Pasquinucci, S ;
Pauluzzi, S ;
Scalzini, A ;
Salassa, B ;
Vincenti, A ;
Phillips, AN ;
Dianzani, F ;
Appice, A ;
Angarano, G ;
Monno, L ;
Ippolito, G ;
Moroni, M ;
Monforte, AD .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :983-991
[20]   Diversity of human immunodeficiency virus type 1 subtype A and CRF03-AB protease in eastern Europe:: Selection of the V77I variant and its rapid spread in injecting drug user populations [J].
Roudinskii, NI ;
Sukhanova, AL ;
Kazennova, EV ;
Weber, JN ;
Pokrovsky, VV ;
Mikhailovich, VM ;
Bobkov, AF .
JOURNAL OF VIROLOGY, 2004, 78 (20) :11276-11287